Proceedings: The influence of PACO2 on the cerebral and peripheral vasodilatory action of papaverin.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects*; D006935:Hypercapnia / Q000503:physiopathology; D010208:Papaverine / Q000494:pharmacology*; D011868:Radioisotopes; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000494:pharmacology*; D014978:Xenon
D011868:Radioisotopes; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D014978:Xenon; D010208:Papaverine